Physician profile
Xinyu Nan
NPI 1326458175
$33,365.47
in general payments reported to CMS, 2019-2025
91 companies · $8,451 in 2025
The $8,451 reported for 2025 was more than what 87% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $1,661 · 2021: $4,523 · 2022: $5,556 · 2023: $5,939 · 2024: $6,990 · 2025: $8,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Long Term Medical Supply Or Device Loan: $2,283 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,935.74 |
| Long Term Medical Supply Or Device Loan | $2,282.65 |
| Education | $160.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,006.17 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $2,130.74 | 2020-2025 | Calquence, Imfinzi, Lynparza |
| Merck Sharp & Dohme LLC | $1,618.16 | 2020-2025 | Keytruda, Welireg, Reblozyl |
| Incyte Corporation | $1,609.20 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Pfizer INC. | $1,513.68 | 2020-2025 | |
| Celgene Corporation | $1,470.48 | 2020-2025 | Reblozyl, Pomalyst, Opdivo |
| Janssen Biotech, INC. | $1,272.00 | 2021-2025 | Tecvayli, Darzalex, Rybrevant |
| Eisai INC. | $1,052.88 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $952.70 | 2020-2025 | Opdivo, Opdualag |
| Lilly USA, LLC | $812.13 | 2020-2025 | Jaypirca, Verzenio, Retevmo |
| Abbvie INC. | $749.33 | 2020-2025 | |
| Astellas Pharma US INC | $733.13 | 2021-2025 | Xtandi, Vyloy, Padcev |
| Daiichi Sankyo INC. | $680.68 | 2020-2025 | Enhertu, Vanflyta, Datroway |
| Takeda Pharmaceuticals U.S.A., INC. | $661.26 | 2020-2025 | Fruzaqla, Alunbrig, Iclusig |
| Genentech USA, INC. | $656.90 | 2021-2025 | Polivy, Phesgo, Tecentriq |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $640.82 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $640.26 | 2020-2025 | |
| Gilead Sciences, INC. | $585.22 | 2022-2025 | Trodelvy |
| Exelixis INC. | $579.31 | 2020-2025 | Cabometyx |
| Alexion Pharmaceuticals, INC. | $575.28 | 2021-2025 | Ultomiris |
| Regeneron Healthcare Solutions, INC. | $572.29 | 2021-2025 | Libtayo |
| Pharmacyclics LLC, An Abbvie Company | $514.23 | 2020-2023 | Imbruvica |
| Array Biopharma INC | $508.07 | 2020-2025 | Mektovi, Braftovi, Tukysa |
| Glaxosmithkline, LLC. | $492.99 | 2020-2025 | Ojjaara, Blenrep, Shingrix |
| Karyopharm Therapeutics INC. | $487.83 | 2020-2025 | Xpovio |
| Seagen INC. | $483.34 | 2021-2023 | Tukysa, Tivdak, Adcetris |
| Amgen INC. | $428.53 | 2020-2025 | Lumakras, Nplate, Vectibix |
| Puma Biotechnology, INC. | $388.97 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $364.90 | 2020-2025 | Gilotrif |
| Emd Serono, INC. | $357.30 | 2021-2025 | Bavencio |
| Taiho Oncology, INC. | $355.25 | 2020-2025 | |
| Aveo Pharmaceuticals, INC. | $336.87 | 2022-2025 | Fotivda |
| Ipsen Biopharmaceuticals, INC | $322.57 | 2021-2025 | Onivyde, Somatuline Depot |
| Blueprint Medicines Corporation | $294.94 | 2020-2025 | Ayvakit |
| Coherus Oncology, INC. | $294.86 | 2021-2025 | Loqtorzi, Udenyca |
| Stemline Therapeutics INC. | $265.86 | 2023-2025 | Orserdu, Elzonris |
| Sobi, INC | $262.83 | 2021-2025 | |
| Beigene USA, INC. | $247.74 | 2020-2024 | Brukinsa |
| Morphosys, US INC. | $180.72 | 2021-2023 | Monjuvi |
| Csl Behring | $165.29 | 2023-2025 | Afstyla, Idelvion |
| Beone Medicines USA, INC. | $152.38 | 2025 | Brukinsa, Tevimbra |
| Ge Healthcare | $143.97 | 2022-2025 | |
| Pharmaessentia USA Corporation | $143.83 | 2023-2025 | Besremi |
| Myovant Sciences INC. | $126.37 | 2021-2022 | |
| Epizyme, INC. | $122.71 | 2021-2022 | |
| Geron Corporation | $116.72 | 2025 | Rytelo |
| Pharmacosmos Therapeutics INC. | $106.05 | 2022-2025 | Monoferric |
| Adc Therapeutics America, INC. | $105.02 | 2022-2025 | |
| Recordati_rare_diseases_inc. | $101.20 | 2023-2025 | Sylvant, Enjaymo |
| Kite Pharma, INC. | $97.80 | 2020-2023 | Yescarta |
| Amag Pharmaceuticals, INC. | $96.37 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $93.60 | 2024-2025 | |
| Genmab U.S., INC. | $93.48 | 2023-2025 | Epkinly |
| Iovance Biotherapeutics, INC. | $88.37 | 2025 | Amtagvi |
| Sumitomo Pharma America, INC. | $86.51 | 2023-2025 | Orgovyx |
| Acrotech Biopharma INC. | $85.74 | 2021-2023 | Beleodaq |
| Agios Pharmaceuticals, INC. | $83.25 | 2021-2024 | Pyrukynd |
| Immunocore Limited | $79.70 | 2024 | Kimmtrak |
| Rigel Pharmaceuticals, INC. | $77.59 | 2020-2025 | Rezlidhia, Tavalisse, Gavreto |
| Deciphera Pharmaceuticals INC. | $71.83 | 2021-2024 | Qinlock, Tgct |
| Immunogen, INC. | $63.69 | 2023 | Elahere |
| Servier Pharmaceuticals LLC | $53.96 | 2021-2024 | |
| Accord Healthcare, INC. | $53.09 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $49.79 | 2020 | |
| Janssen Pharmaceuticals, INC | $49.25 | 2022 | |
| Foundation Medicine, INC. | $45.53 | 2023 | |
| Caris Mpi, INC. | $44.32 | 2025 | Mi Cancer Seek |
| Acceleron Pharma, INC. | $44.03 | 2021 | |
| Dova Pharmaceuticals | $41.40 | 2020-2021 | |
| Cti Biopharma Corp. | $39.55 | 2022-2023 | Vonjo |
| Eusa Pharma (US) LLC | $39.05 | 2020-2021 | |
| Cumberland Pharmaceuticals, INC. | $38.76 | 2023-2025 | Sancuso |
| Sirtex Medical INC | $36.22 | 2020-2023 | Sir-Spheres Microspheres |
| Secura Bio, INC. | $34.37 | 2024 | Copiktra |
| Mirati Therapeutics, INC. | $33.91 | 2023 | Krazati |
| Tempus Ai, INC | $28.84 | 2024 | |
| Legend Biotech USA INC. | $28.39 | 2024 | |
| Syndax Pharmaceuticals, INC. | $28.16 | 2025 | |
| Invivyd INC | $26.34 | 2025 | Pemgarda |
| Dendreon Pharmaceuticals LLC | $25.09 | 2023 | Provenge |
| Kyowa Kirin, INC. | $24.49 | 2024 | Poteligeo |
| Springworks Therapeutics, INC. | $23.70 | 2024 | Ogsiveo |
| Genentech, INC. | $23.62 | 2023 | Columvi, Lunsumio |
| Boston Scientific Corporation | $22.86 | 2024 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Clovis Oncology, INC. | $21.81 | 2020 | |
| Apellis Pharmaceuticals, INC. | $21.61 | 2023 | Empaveli |
| G1 Therapeutics, INC. | $20.05 | 2023 | Cosela |
| Tg Therapeutics, INC. | $19.45 | 2022 | |
| Novocure INC. | $18.02 | 2020 | |
| Spectrum Pharmaceuticals INC. | $14.46 | 2024 | Rolvedon |
| Aurobindo Pharma USA, INC. | $13.46 | 2020 |
Drugs and devices associated with these payments
Kisqali $2,421Keytruda $939Reblozyl $749Enhertu $652Lenvima $576Ultomiris $492Lynparza $446Jakafi $423Calquence $417Imbruvica $416Libtayo $415Cabometyx $406Opdivo $406Braftovi $399Mektovi $399Tukysa $398Xtandi $397Imfinzi $394Monjuvi $359Epkinly $339Padcev $311Welireg $305Tecvayli $288Jaypirca $278Fruzaqla $270Fotivda $262Verzenio $253Orserdu $247Trodelvy $246Elrexfio $243Opdualag $237Nubeqa $232Elahere $229Alunbrig $229Darzalex $227Xpovio $226Inlyta $219Adcetris $216Brukinsa $214Inqovi $208Lonsurf $208Somatuline Depot $204Onivyde $204Lorbrena $191Pemazyre $184Ojjaara $179Bosulif $175Pluvicto $165Afstyla $165Idelvion $165Ayvakit $165Retevmo $165Polivy $164Rybrevant $160Gilotrif $154Sarclisa $154Erleada $151Orgovyx $148Besremi $144Fabhalta $142Talvey $139Vonjo $137Talzenna $136Pomalyst $136Phesgo $133Nerlynx $122Stivarga $122Rytelo $117Tecentriq $109Vanflyta $106Zynyz $103Loqtorzi $102Vyloy $94.41Ibrance $91.89Vitrakvi $91.62Piqray $91.28Iclusig $91.18Keytruda Qlex $90.46Tivdak $90.34Monoferric $89.81Carvykti $89.00Amtagvi $88.37Venclexta $82.06Bavencio $80.08Kimmtrak $79.70Lutathera $79.01Xofigo $78.93Doptelet $73.99Udenyca $71.28Pyrukynd $69.77Tagrisso $68.17Rezlidhia $66.61Tavalisse $66.61Sylvant $64.54Jevtana $57.87Promacta $57.75Datroway $56.73Columvi $56.39Lunsumio $56.39Mekinist $54.53
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xinyu Nan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.